Company / Book Value per Share
Cogent Biosciences, Inc. Book Value per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$4.937
FY2025
5-year range
$2.468 / $5.53
FY2021-FY2025
Trend
+100.1%
vs FY2024
Sector context
#108 of 211
Health Care
What the data says
At $4.937, Cogent Biosciences, Inc.'s book value per share ranks #108 of 211 in the Health Care sector. Book Value per Share returned to growth in FY2025 after 4 years of decline, reaching $4.937.
Based on SEC 10-K filings.
$4.937 in FY2025 with a 5-year CAGR of -25.3%.
Improved from $3.236 to $4.937 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- +4.3%
- 5-Year CAGR
- -25.3%
- 10-Year CAGR
- -
Sector benchmark
#108 of 211 in Health CareTop 51% of 211This company $4.937 Sector average $213.854
▼
-97.7% below sector average
Key checks
Key Insights
- 5-year CAGR of -25.3%, indicating a declining trend.
- In FY2025, book value per share increased 100.1% year-over-year.
- Ranks #108 out of 211 companies in the Health Care sector.
- Peak book value per share was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.43 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.937 | +100.1% |
| FY2024 | $2.468 | -23.8% |
| FY2023 | $3.236 | -25.7% |
| FY2022 | $4.354 | -21.3% |
| FY2021 | $5.53 | -73.9% |
| FY2020 | $21.177 | +408.1% |
| FY2019 | $4.168 | +72.3% |
| FY2018 | $2.419 | +150.5% |
| FY2017 | -$4.793 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026